(75 MHz D2O + DCl) 22.9, 40.9, 43.1, 66.7, 116.2, 123.8,
156.3 and 169.5; m/z (APCI) 216 (MH+). Found: C, 42.80; H,
6.18; N, 18.65%. Calc. for C8H13N3O2S × 0.5H2O: C, 42.84; H,
6.29; N, 18.74%.
Notes and references
1 See for example: J. T. Brosnan and M. E. Brosnan, J. Nutr., 2006, 135,
1636S–1640S; A. Agbas and J. Moskovitz, Curr. Signal Transduction
Ther., 2009, 4, 46–50; C. Klomsiri, P. A. Karplus and L. B. Poole, Anti-
oxid. Redox Signaling, 2011, 14, 1065–1077.
2 An imidazole-thione group is in tautomeric thione/thiol equilibrium, but
at physiological pH, the thione form predominates strongly, see:
N. Motohashi, I. Mori and Y. Sugiura, Chem. Pharm. Bull., 1976, 24,
1737–1741. This explains the striking air-stability of aqueous solutions of
2-thiohistidine compounds such as ergothioneine compared to other bio-
logical important thiols, such as cysteine or glutathione
Oxidative cysteine introduction using alternative methods
(Table 4)
3 P. André, C. Marteau, I. Renimel and M. Marielle, US Pat., 7 935 359,
2011.
Method A (Table 4, entry 1): Hydrogen peroxide (30%, 736 mg,
6.5 mmol, 1.3 equiv.) was added dropwise to a solution of
hydrobromic acid (2.19 g, 1.47 mL, 13 mmol, 2.6 equiv.) in
water (10 mL). After stirring for 18 h at room temperature in a
closed vessel, the orange-red solution was cooled to 0 °C. Histi-
dine hydrochloride hydrate (1.05 g, 5 mmol, 1 equiv.) was added
and, after 5 min at 0 °C, cysteine (1.85 g, 15 mmol, 3 equiv.).
After stirring for 1 h at 0 °C, 200 μL of the reaction mixture
were diluted in 500 μL D2O, filtered, and the solution analyzed
by 1H NMR (400 MHz).
4 K. K. Makinen and P. L. Makinen, Biosci. Rep., 1982, 2, 169–175.
5 Up to now, 2-thiohistidine (3a) has not yet been identified as a naturally
occurring amino acid, but it is found in the peptide sequence of important
enzymes such as tyrosinase, where it is located near the metal-containing
active site (K. Lerch, J. Biol. Chem., 1982, 257, 6414–6419). In peptide
synthesis, it is applied to introduce conformational rigidity (C. Gielens,
K. Idakieva, M. De Maeyer, V. Van Den Bergh, N. I. Siddiqui and
F. Compernolle, Peptides, 2007, 28, 790–797) and in drug discovery to
systematically study the role of histidine and cysteine residues by repla-
cing them with the thiohistidine fragment (see for example W. Shen,
K. J. Barr, J. D. Oslob and M. Zhong, WO2005/044817)
Method B (Table 4, entries 2 and 5): Hydrobromic acid
(2.19 g, 1.47 mL, 13 mmol, 2.6 equiv.) was added dropwise to a
cooled solution of Oxone (2.0 g, 6.5 mmol, 1.3 equiv.) in water
(10 mL) at 0 °C. After stirring for 15 min at room temperature
in a closed vessel, histidine (5 mmol, 1 equiv. for entry 2) or
hercynine (8, 986 mg, 5 mmol, 1 equiv. for entry 5) was
added and, after 5 min at 0 °C, cysteine (1.85 g, 15 mmol,
3 equiv. for entry 2; 3.09 g, 25 mmol, 5 equiv. for entry 5). After
stirring for 1 h at 0 °C, 200 μL of the reaction mixture were
diluted in 500 μL D2O, filtered, and the solution analyzed by
1H NMR.
Method C (Table 4, entries 3 and 6): Hydrochloric acid (37%,
1.2 g, 1.1 mL, 13 mmol, 2.6 equiv.) was added dropwise to a
cooled solution of histidine hydrochloride hydrate (5 mmol,
1 equiv. for entry 3) or hercynine hydrochloride (5 mmol,
1 equiv. for entry 6), sodium bromide (1.14 g, 11 mmol) and
sodium bromate (0.33 g, 2.2 mmol) in water (10 mL) at 0 °C.
Cysteine (1.85 g, 15 mmol, 3 equiv. for entry 3; 3.09 g,
25 mmol, 5 equiv. for entry 6) was added after 5 min at 0 °C.
After stirring for 1 h at 0 °C, 200 μL of the reaction mixture
were diluted in 500 μL D2O, filtered, and the solution analyzed
by 1H NMR.
6 C. Tanret, C. R. Acad. Sci., 1909, 149, 222–224.
7 I. K. Cheah and B. Halliwell, Biochim. Biophys. Acta, Mol. Basis Dis.,
2012, 1822, 784–793.
8 S. D. Genghof and O. Van Damme, J. Bacteriol., 1970, 103, 475–478.
9 S. D. Genghof, J. Bacteriol., 1964, 87, 852–862.
10 D. Grundemann, S. Harlfinger, S. Golz, A. Geerts, A. Lazar, R. Berkels,
N. Jung, A. Rubbert and E. Schornig, Proc. Natl. Acad. Sci. U. S. A.,
2005, 102, 5256–5261.
11 B. D. Paul and S. H. Snyder, Cell Death Differ., 2009, 17, 1134–1140.
12 J. Xu and J.-C. Yadan, J. Org. Chem., 1995, 60, 6296–6301.
13 M. Trampota, US Pat., 7 767 826, 2010.
14 Y. Ishikawa and D. B. Melville, J. Biol. Chem., 1970, 245, 5967–5973.
15 F. P. Seebeck, J. Am. Chem. Soc., 2010, 132, 6632–6633.
16 Y. Ishikawa, S. E. Israel and D. B. Melville, J. Biol. Chem., 1974, 249,
4420–4427.
17 Another difference between the biosynthesis and a common feature of
both chemical preparations is the fate of the imidazole-cycle during sulfur
introduction: while the imidazole moiety of hercynine is completely con-
served during the enzymatic sulfur-introduction, it is cleaved in the
chemical processes, either via a Bamberger-type or by an ANRORC-
sequence (see ref. 12)
18 M.-O. Simon and C.-J. Li, Chem. Soc. Rev., 2012, 41, 1415–1427.
19 For numerous examples see: Protective Groups in Organic Synthesis, ed.
T. W. Greene and P. G. M. Wuts, John Wiley & Sons, New York, 4th
Revised edn, 2006; Protecting Groups, ed. P. J. Kocienski, Georg Thieme
Verlag, Stuttgart, 3rd edn, 2005.
20 T. Newhouse, P. S. Baran and R. W. Hoffmann, Chem. Soc. Rev., 2009,
38, 3010–3021.
21 R. W. Hoffmann, Synthesis, 2006, 3531–3541; I. S. Young and
P. S. Baran, Nat. Chem., 2009, 1, 193–205; R. A. Shenvi, D. P. O’Malley
and P. S. Baran, Acc. Chem. Res., 2009, 42, 530–541; E. M. Dangerfield,
C. H. Plunkett, B. L. Stocker and M. S. M. Timmer, Molecules, 2009, 14,
5298–5307.
22 See for example: J. McNulty, P. Das and D. McLeod, Chem.–Eur. J.,
2010, 16, 6756–6760; J. Liu, X. Deng, A. E. Fitzgerald, Z. S. Sales,
H. Venkatesan and N. S. Mani, Org. Biomol. Chem., 2011, 9, 2654–
2660.
23 J. E. Klijn and B. F. N. Engberts, Nature, 2005, 435, 746–748; C.-J. Li,
Chem. Rev., 2005, 105, 3095–3165; U. M. Lindström and F. Andersson,
Angew. Chem., Int. Ed., 2006, 45, 548–551.
24 L-Hercynine can be prepared in two steps and 73% global yield from
L-histidine: V. N. Reinhold, Y. Ishikawa and D. B. Melville, J. Med.
Chem., 1968, 11, 258–260.
Method D (Table 4, entries 4 and 7): Hydrochloric acid (37%,
0.64 g, 0.55 mL, 6.6 mmol, 1.3 equiv.) was added dropwise to a
cooled solution of histidine hydrochloride hydrate (5 mmol,
1 equiv. for entry 4) or hercynine hydrochloride (5 mmol,
1 equiv. for entry 7), sodium bromide (0.45 g, 4.33 mmol) and
sodium bromate (0.33 g, 2.2 mmol) in water (10 mL) at 0 °C.
Cysteine (1.85 g, 15 mmol, 3 equiv. for entry 4; 3.09 g,
25 mmol, 5 equiv. for entry 7) was added after 5 min at 0 °C.
After stirring for 1 h at 0 °C, 200 μL of the reaction mixture
were diluted in 500 μL D2O, filtered, and the solution analyzed
by 1H NMR.
25 Cysteine is produced in several thousand tons per year by extraction or
fermentation (W. Leuchtenberger, K. Huthmacher and K. Drauz, Appl.
Microbiol. Biotechnol., 2005, 69, 1–8; A. Ault, J. Chem. Educ., 2004,
81, 347–355)
Acknowledgements
26 S. Ito, J. Org. Chem., 1985, 50, 3636–3638.
The authors would like to thank Dr Marc Moutet (Tetrahedron)
for helpful discussions.
27 As 13 had been synthesized in small amounts in the study of the bio-
synthesis of ergothioneine (see ref. 16) from chloroalanine and
2264 | Green Chem., 2012, 14, 2256–2265
This journal is © The Royal Society of Chemistry 2012